Literature DB >> 15114054

Essential role of OX40L on B cells in persistent alloantibody production following repeated alloimmunizations.

Hiroshi Kato1, Hidefumi Kojima, Naoto Ishii, Hidenori Hase, Yutaka Imai, Takashi Fujibayashi, Kazuo Sugamura, Testuji Kobata.   

Abstract

OX40/OX40 ligand (OX40L) interactions are implicated in costimulation for both CD4(+) T and B cells in a bidirectional manner. To determine the role of OX40/OX40L interactions in recipient antidonor responses after multiple allogeneic transfusions, we examined alloreactive cytotoxic T lymphocyte (allo-CTL) activity and alloantibody production in repeatedly alloimmunized OX40L-deficient mice. After the fifth alloimmunization, whereas OX40L-deficient mice showed allo-CTL activity with levels comparable to those of wild-type mice, alloantibody production in OX40L-deficient mice was significantly reduced, accompanied by fewer memory B and CD4(+) T cells with reduced function. Furthermore, nu/nu mice that received OX40L-deficient T cells still exhibited impaired alloantibody production with fewer memory CD4(+) T and B cells. In contrast, RAG-2-deficient mice that received both wild-type T cells and OX40L-deficient B cells produced scant alloantibodies with fewer memory B cells, but sufficient memory CD4(+) T cells. Thus, OX40L on B cells, rather than on T cells, is apparently required for adequate and persistent production of alloantibodies after repeated alloimmunizations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15114054     DOI: 10.1023/B:JOCI.0000025445.21894.e5

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  61 in total

1.  Intracellular signaling of gp34, the OX40 ligand: induction of c-jun and c-fos mRNA expression through gp34 upon binding of its receptor, OX40.

Authors:  Y Matsumura; T Hori; S Kawamata; A Imura; T Uchiyama
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

2.  Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses.

Authors:  I Gramaglia; A D Weinberg; M Lemon; M Croft
Journal:  J Immunol       Date:  1998-12-15       Impact factor: 5.422

3.  Signaling through OX40 (CD134) breaks peripheral T-cell tolerance.

Authors:  P Bansal-Pakala; A G Jember; M Croft
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

4.  OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells.

Authors:  P R Rogers; J Song; I Gramaglia; N Killeen; M Croft
Journal:  Immunity       Date:  2001-09       Impact factor: 31.745

5.  Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration.

Authors:  G Andreu; J Dewailly; C Leberre; M C Quarre; M L Bidet; R Tardivel; L Devers; Y Lam; E Soreau; C Boccaccio
Journal:  Blood       Date:  1988-09       Impact factor: 22.113

6.  OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors.

Authors:  Y Ohshima; L P Yang; T Uchiyama; Y Tanaka; P Baum; M Sergerie; P Hermann; G Delespesse
Journal:  Blood       Date:  1998-11-01       Impact factor: 22.113

7.  Effects of leukocyte depletion and UVB irradiation on alloantigenicity of major histocompatibility complex antigens in platelet concentrates: a comparative study.

Authors:  K J Kao
Journal:  Blood       Date:  1992-12-01       Impact factor: 22.113

8.  UVB irradiation of human platelet concentrates does not prevent HLA alloimmunization in recipients.

Authors:  M A Grijzenhout; M I Aarts-Riemens; F R de Gruijl; H van Weelden; H C van Prooijen
Journal:  Blood       Date:  1994-11-15       Impact factor: 22.113

9.  Indirect allorecognition of platelets by T helper cells during platelet transfusions correlates with anti-major histocompatibility complex antibody and cytotoxic T lymphocyte formation.

Authors:  J W Semple; E R Speck; Y P Milev; V Blanchette; J Freedman
Journal:  Blood       Date:  1995-07-15       Impact factor: 22.113

Review 10.  Role of OX40 signals in coordinating CD4 T cell selection, migration, and cytokine differentiation in T helper (Th)1 and Th2 cells.

Authors:  P Lane
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

View more
  6 in total

Review 1.  Tumor necrosis factor/tumor necrosis factor receptor family members that positively regulate immunity.

Authors:  Takanori So; Seung-Woo Lee; Michael Croft
Journal:  Int J Hematol       Date:  2006-01       Impact factor: 2.490

2.  Altered expression of TNFSF4 and TRAF2 mRNAs in peripheral blood mononuclear cells in patients with systemic lupus erythematosus: association with atherosclerotic symptoms and lupus nephritis.

Authors:  Peyman Rajabi; Mahsa Alaee; Kazem Mousavizadeh; Ali Samadikuchaksaraei
Journal:  Inflamm Res       Date:  2012-07-31       Impact factor: 4.575

Review 3.  Association of the co-stimulator OX40L with systemic lupus erythematosus.

Authors:  Harinder Manku; Deborah S Cunninghame Graham; Timothy J Vyse
Journal:  J Mol Med (Berl)       Date:  2008-12-16       Impact factor: 4.599

4.  Monosomy 1p36 uncovers a role for OX40 in survival of activated CD4+ T cells.

Authors:  M M Suhoski; E E Perez; M L Heltzer; A Laney; L G Shaffer; S Saitta; S Nachman; N B Spinner; C H June; J S Orange
Journal:  Clin Immunol       Date:  2008-06-03       Impact factor: 3.969

5.  OX40 ligand expression abrogates the immunosuppressive function of retinal pigment epithelium.

Authors:  Matthew A Cunningham; Zhuqing Li; Baoying Liu; Steven Yeh; Robert B Nussenblatt
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-01-15

6.  Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis.

Authors:  Pravitt Gourh; Frank C Arnett; Filemon K Tan; Shervin Assassi; Dipal Divecha; Gene Paz; Terry McNearney; Hilda Draeger; John D Reveille; Maureen D Mayes; Sandeep K Agarwal
Journal:  Ann Rheum Dis       Date:  2009-09-23       Impact factor: 19.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.